xCures - Technology Platform uses Artificial Intelligence (A.I.)
The xCures technology platform uses artificial intelligence (A.I.) and predictive modeling to identify and rank the most promising treatment options for people with cancer who have exhausted the standard of care.
The xCures platform transforms complex unstructured medical data directly from the patient’s medical records into structured data suitable for analysis and machine learning. Our A.I. engine then actively cross-references this data against the vast digital library of oncology data to match patients with potential treatments and predict outcomes. This empowers patients and their oncologists to make more informed and effective treatment decisions.
At the center of the xCures platform is our highly specialized Natural Language Processor (NLP) that can read, interpret, and encode raw unstructured patient data from anywhere in the United States. Our NLP speaks the language of oncology. The result is structured patient data in a crisp case summary for use by patients, doctors, researchers, as well as payers, pharma and AI algorithms
Access to the xCures platform is provided free of charge to help patients and physicians find the most effective treatments to fight their advanced cancer diagnosis.
xCures is building a community of support and data that patients and their doctors can continually use and share throughout their treatment.
xCures provides access portals for both patients and medical providers:
Designed for patients: Uses A.I.-powered clinical data analysis to spotlight the most promising treatments and surface expert-sourced insights tailored to each patient’s cancer characteristics.
Designed for physicians: Treatment decision support and patient case visualization portal.
Spend your time evaluating treatment options for patients, not researching them.
Designed for physicians: Expands xINFORM scope and uses natural language processing to transform a patient’s raw medical records into a structured oncological timeline. This HIPAA compliant process facilitates seamless enrollment to Managed Access Programs and other clinical studies.